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The mammalian circadian system, which is comprised of multiple cellular clocks located in the organs and
tissues, orchestrates their regulation in a hierarchical manner throughout the 24 hr of the day. At the top of
the hierarchy are the suprachiasmatic nuclei, which synchronize subordinate organ and tissue clocks using
electrical, endocrine, and metabolic signaling pathways that impact the molecular mechanisms of cellular
clocks. The interplay between the central neural and peripheral tissue clocks is not fully understood and
remains a major challenge in determining how neurological and metabolic homeostasis is achieved across
the sleep-wake cycle. Disturbances in the communication between the plethora of body clocks can
desynchronize the circadian system, which is believed to contribute to the development of diseases such
as obesity and neuropsychiatric disorders. This review will highlight the relationship between clocks and
metabolism, and describe how cues such as light, food, and reward mediate entrainment of the circadian
system.
Introduction
Circadian clocks generate self-sustaining, cell-autonomous
oscillations with a time period of approximately 24 hr (circa
diem, approximately one day). Such oscillations are thought to
have evolved in response to the daily light/dark rhythms, which
are associated with food availability; it is believed that the
internalization of the 24 hr rhythms of light and dark made it
advantageous to the organism to predict daily recurring events
even when conditions remained constant (e.g., constant dark-
ness). Hence, organisms that are able to take advantage of
the daily variations in light by staying in tune with the environ-
mental light/dark cycle outgrow organisms that cannot; this
growth difference has been conclusively shown in cyanobacteria
(Ouyang et al., 1998).
In multicellular organisms such as mammals, organs form
a hierarchically structured circadian system, with the brain and
the liver serving an important coordinating function. This system
has been optimized for adaptation and survival (Figure 1A).
Because individual cells contain circadian clocks (Balsalobre
et al., 1998), these individual oscillators need to be synchronized
within the tissue. In turn, tissues are kept in a stable phase-rela-
tionship with each other to render clock information useful for the
entire multicellular organism. To build such a coherent circadian
system, cellular clocks must be able to respond to a stimulus
(e.g., input from other cells), integrate the phase information
regarding when the stimulus occurred into their molecular intra-
cellular clockmechanism, and transfer clock information to other
cells (output) (Figure 1B). This organization is schematically
repeated at the systems level where signals, such as light
detected by the retina (input, external environment), are trans-
mitted to the suprachiasmatic nuclei (SCN) (clock). There, light
signals are integrated to adjust the information about time (see
below). Subsequently, this elicits a change in the onset of certain
behaviors and tissue activities (output) (Figure 1B). Conversely,
tissue signals representing the internal environment may return
information to the clock (Figure 1B, purple arrows). Thus, the
hallmarks of organization in a circadian timing system are the
perception of the environmental input, integration of time-related
information into the autonomous circadian clock device, trans-
mission of adjusted timing information to metabolic and physio-
logical processes, and subsequent feedback of tissue informa-
tion (Eskin, 1979). The circadian system must continuously
adapt to and synchronize with the environment and the body’s
internal signals in order to organize individual cellular clocks
and combine tissue subnetworks into a coherent functional
network that regulates behavior and physiology.
In the following sections, I will review advances made in
understanding the central and peripheral components of this
clockwork mechanism, and discuss critical factors from the
environment (light and food) that serve as signals to synchronize
the circadian system. Particular attention will be paid to the inter-
play between the circadian clock and metabolism for internal
clock synchronization. Finally, I will discuss the implications of
proper clock synchronization for human health and disease.
Molecular Clockwork
The molecular mechanisms that drive circadian oscillations in
mammalian cells have been revealed during the last decade.
The two main processes that form the foundation of these
rhythms are the oscillating posttranslational modiﬁcations of
proteins (e.g., phosphorylation) and the transcriptional-transla-
tional feedback loop (TTL) (Figure 2A). The TTL comprises of
a positive and a negative limb that are interconnected (the blue
and purple lines in Figure 2A). In the positive limb of the mamma-
lian system, the transcriptional activator protein BMAL (isoforms
1 and 2) (Hogenesch et al., 1998; Shi et al., 2010) dimerizes with
CLOCK (or NPAS2 in brain tissue) (Gekakis et al., 1998; Reick
et al., 2001), and this heterodimer binds to the E-box promoter
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elements (CACGTG) present in clock and clock-controlled genes
(CCGs). The clock genes Period (isoforms Per1 and Per2) (Zheng
et al., 2001) andCryptochrome (isoformsCry1 andCry2) (van der
Horst et al., 1999), when activated in this manner, constitute
the negative portion of the TTL. The mRNA of these genes is
translated in the cytoplasm, and the resulting proteins form
heterodimers that eventually enter the nucleus to inhibit tran-
scription by binding to the BMAL/CLOCK (or NPAS2) complex
A
B
Figure 1. Organization of the Circadian
System
(A) Circadian clocks are found in all cells of various
organs. The master clock is located in the SCN
(red circle) of the brain and synchronizes the other
central clocks that are related to metabolic and
reward integration (yellow-blue shaded oval)
andmotor coordination (purple oval) via direct and
indirect pathways (yellow lines). The SCN and the
pineal clock (red oval) are sensitive to light (orange
lines). Hormonal signaling between organs is
shown: melatonin (brown line); ghrelin (dark
green); leptin (light green); insulin/glucagon (pink,
hatched line = insulin only) and adrenaline (blue).
Metabolic signaling between organs is shown:
carbohydrates, fatty acids, and amino acids
(black). Purple: neuronal connections between the
brain, spinal cord and muscles.
(B) Subdivision of the circadian system: input to
the clock, clock mechanism, and clock output.
This division can be made at the cellular level
(top) as well as at the systemic level (bottom).
Synchronization between cellular clocks becomes
an issue inmulticellular systems, such as in organs
and in entire organisms (see A).
(Kume et al., 1999). The PER/CRY multi-
mers recruit a PSF/Sin3-HDAC complex,
shutting down transcription by deacety-
lating histones 3 and 4 (Duong et al.,
2011). Other histone-modifying enzymes,
such as JARID1a, also seem to inﬂuence
circadian transcription (DiTacchio et al.,
2011). The positive and negative limbs
are connected by nuclear receptors
from the REV-ERB and ROR families.
These receptors are transcriptionally
regulated by the positive limb and acti-
vate (ROR) or inhibit (REV-ERB) transcrip-
tion of the Bmal (Preitner et al., 2002;
Sato et al., 2004, Cho et al., 2012),
Npas2 (Crumbley et al., 2010), and Clock
(Crumbley and Burris, 2011) genes
(Figure 2, blue), thereby modulating their
own activators. This process is ﬁne tuned
by the PER2 protein, which interacts with
REV-ERBa (Schmutz et al., 2010) to
synchronize the negative and positive
limbs of the TTL (Figure 2A, purple arrow).
The nicotinamide phosphoribosyl-
transferase (NAMPT) gene, a CCG that
feeds back on the clock mechanism,
codes for the rate-limiting enzyme for
adenine dinucleotide (NAD+) synthesis in the mammalian
salvage pathway of nicotinamide (Figure 2A, brown arrows).
NAD+ functions as a metabolic oscillator and regulates the
core clock machinery via SIRT1 (Nakahata et al., 2009; Ramsey
et al., 2009), which is a histone deacetylase, to modulate tran-
scriptional activity of the clock (Asher et al., 2008; Nakahata
et al., 2008). Hence, metabolic processes affecting levels of
NAD+, representing the internal environment, feed back on the
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clock mechanism, illustrating that the elements of clock output
can affect the clock itself (Figure 1B, purple arrows).
The NAMPT promoter is modulated by clock components via
E-box elements. However, not all CCGs are driven in a circadian
fashion by this mechanism. Promoter analysis and systems-
biological approaches have revealed that nuclear receptor
elements (NREs) are an additional transcriptional module
that underlies mammalian circadian clocks (Ueda et al., 2002)
(Figure 2B). The binding of nuclear receptors (e.g., REV-ERBa,
PPARa, andGlucocorticoid receptor) to such promoter elements
is modulated by PER2 (Schmutz et al., 2010) or Cryptochromes
(CRY) (Lamia et al., 2011) (Figure 2B, hatched line). Furthermore,
D-box elements have been recognized as the third important
factor that regulates circadian transcription (Ueda et al., 2005).
These elements are occupied by PAR-Zip transcription factors
A
B
Figure 2. Molecular Circadian Clock
Mechanisms in a Cell
(A) The clock mechanism consists of two main
parts: (1) a transcriptional-translational feedback
loop (TTL) consisting of a positive (green +) and
a negative (red ) limb and (2) oscillating post-
translational modiﬁcation of gene products in the
TTL (yellow circle marked with P), which regulate
degradation and/or nuclear localization of these
proteins (orange arrows).
The positive and negative limbs are intertwined via
clock protein-driven nuclear receptors (blue lines)
and their interactions with PER2, a component of
the negative limb (purple arrow). A metabolic
oscillator (brown M) is driven by the TTL and feeds
back on it via SIRT1 (for details, see text).
(B) Promoter elements in clock controlled genes
(CCGs). The CCGs are regulated either directly or
indirectly. (1) Direct regulation via BMAL/CLOCK
binding at E-boxes or REV-ERB/ROR binding at
RORE-elements and (2) Indirect regulation via
binding of clock-regulated PAR-ZIP factors (e.g.,
DBP) on D-elements, or via protein-protein inter-
actions between PER2 and nuclear receptors
(hatched line) at nuclear receptor elements (NREs)
such as ROREs.
(e.g., Dbp) that are themselves under the
control of E-box-mediated transcription,
and therefore, they modulate CCGs indi-
rectly in a circadian manner (Lavery
et al., 1999) (Figure 2B).
Transcriptional regulation is not the
sole mechanism responsible for the
generation of circadian oscillations. In
mammalian cells, circadian oscillations
in gene expression are largely unper-
turbed by cell division (Nagoshi et al.,
2004), and mammalian clocks are resis-
tant to large changes in transcription
rate (Dibner et al., 2009). Posttranslational
events that modulate protein half-life and
subcellular localization appear to contri-
bute signiﬁcantly to circadian oscillations
(Figure 2A, orange arrows). Various
kinases and phosphatases regulate the
speed, precision, and function of the circadian clock (reviewed
in Vanselow and Kramer, 2010). Recent studies have implicated
a number of microRNAs (miRNAs) (Cheng et al., 2007) and
several RNA-binding protein complexes in the regulation of
circadian polyadenylation, splicing, RNA stabilization, and
degradation (reviewed in Pegoraro and Tauber, 2008). Thus,
the regulation of circadian rhythms in a cell is controlled by
multiple processes involving the expression of genes, from
DNA to RNA to protein.
SCN, Retinal Input, and Other Clocks in the Brain
In mammals, the circadian timing system is composed of virtu-
ally as many clocks as there are cells in the body. A signiﬁcant
question is how all these clocks are synchronized to one another
and whether a primary pacemaker governing the multitude of
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clocks exists. Ablation and transplantation experiments have
revealed such a pacemaker in the hypothalamus. It is located
in nuclei just above the optic chiasm and is hence termed
the suprachiasmatic nuclei (SCN). The SCN are important for
rhythmic hormone secretion and locomotor activity (Lehman
et al., 1987) and being at the top of the hierarchical organization
of the circadian timing system (Figures 1A and 3A). As such they
serve as a central conductor orchestrating the other clocks and
thus entraining the circadian system to the environmental light/
dark cycle.
Light information is perceived primarily via intrinsically photo-
sensitive retinal ganglion cells (ipRGCs) in the retina, which
express the photopigment melanopsin. These cells send photic
information directly to the SCN via the RHT (Figure 3B). The
A
B C
Figure 3. Schematic Representation of Light Input and Intercellular Signaling Mechanisms in the SCN
(A) Main afferent pathways to the SCN in the rat. Orange arrows: photic input; blue arrows: nonphotic input to the SCN; 5HT, serotonin; DRN, dorsal raphe
nucleus; IGL, intergeniculate leaﬂet; GABA, gamma-aminobutyric acid; GHT, geniculohypothalamic tract; Glu, glutamate; MRN, median raphe nucleus; NPY,
neuropeptide Y; PACAP, pituitary adenylate cyclase-activating peptide; RHT, retinohypothalamic tract; SCN, suprachiasmatic nuclei.
(B) Schematic representation of the retina. Intrinsically photosensitive retinal ganglion cells (ipRGCs) project to the SCN via the retinohypothalamic tract (RHT) to
transmit light information. Rods (R); cones (Co); horizontal cells (H); bipolar cells (B); amacrine cells (Am) and regular retinal ganglion cells (RGC) transmit
information about color and shape to the tectum.
(C) Signal transduction pathways in the SCN. Light input to the SCN: orange RHT synapse releasing glutamate (Glu, green), leading to kinase activation and
expression of immediate early genes (IEG) resulting in a phase shift of the circadian clock. Glutamate is eventually cleared from the synaptic cleft via glutamate
transporters (gray) on astrocytes (light purple). Intercellular signaling: vasointestinal peptide (VIP, purple dots); arginine vasopressin (AVP, black dots); gamma-
aminobutyric acid (GABA, red dots); gastrin-releasing peptide (GRP, yellow dots) and gap junctions are involved (for details see text). AC, adenylate cyclase; AP,
action potential; cAMP, cyclic adenosine-mono-phosphate; CRE, cAMP response element; CREB, CRE binding protein; PKA, protein kinase A (modiﬁed from
Dibner et al., 2010, and Welsh et al., 2010).
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monosynaptic RHT ﬁbers terminate in the ventrolateral part of
the SCN, directly onto neurons that express vasoactive intestinal
polypeptide (VIP). Light stimulation of the retina during the
subjective night leads to the release of the neurotransmitters
glutamate (Glu) and pituitary adenylate cyclase-activating
protein (PACAP) at the terminal synapses of the RHT, and the
signal is then propagated to the SCN (Figures 3B and 3C)
(reviewed in Ecker et al., 2010). This leads to the activation of
several signaling pathways that evoke chromatin remodeling
and the induction of immediate early genes and clock genes
(reviewed in Golombek and Rosenstein, 2010). As a conse-
quence, the circadian clock phase is changed, and this alteration
can be readily observed (e.g., a change in the onset of wheel
running activity in rodents, reviewed in Antle et al., 2009).
Retinal neurons of the RHT signal only to a small subset of
SCN cells, which then transmit retinal information to their neigh-
boring cells. This, together with the observation that expression
of neuropeptides within the SCN is not homogeneous, showed
that the SCN are a network of functionally and phenotypically
differentiated cells (reviewed in Antle and Silver, 2005). These
individual cellular oscillators are coupled to produce a consistent
circadian oscillation within the SCN. The mechanisms involved
include neurochemical signals such as vasoactive intestinal
polypeptide (VIP), arginine vasopressin (AVP), GABA, ghrelin-
releasing peptide (GRP), and gap junctions (Figure 3C) (reviewed
in Welsh et al., 2010).
The SCN are not the only structure in the brain displaying
daily oscillations. Nuclei in the thalamus and hypothalamus,
amygdala, hippocampus, habenula, and the olfactory bulbs
show such oscillations (reviewed in Guilding and Piggins,
2007). The most robust rhythms, beyond those observed in the
SCN, are found in the olfactory bulbs and tissues that have
neuroendocrine functions. These brain areas include the arcuate
nucleus (ARC), the paraventricular nucleus (PVN), and the pitui-
tary gland.
Studies in intact animals have documented that signals from
the SCN can synchronize populations of weakly coupled or non-
coupled cells in the brain, and neuronal projections between
these different, non-SCN brain regions may assist in maintaining
circadian rhythms via neuronal circuits (Colwell, 2011). These
circuits are critical not only for keeping circadian oscillations
constitutive but also for regulating physiology and behavior,
such as the integration of metabolic information and reward-
driven behaviors that occur within a 24 hr time period (see
below).
Peripheral Clocks and Metabolism
Peripheral circadian clocks, such as those that are found in the
liver, are inﬂuenced by the autonomic nervous system and by
systemic cues including body temperature, hormone metabo-
lites, and feeding/fasting cycles (see Figure 1). Although the
SCN serves as the master synchronizer of the entire system,
food intake can uncouple peripheral clocks from control by the
SCN. Through changes in feeding schedule, the phase relation-
ship between the central clock in the SCN and the clocks in the
liver can be altered (Damiola et al., 2000), suggesting that
changes in metabolism caused by alterations in feeding rhythm
may affect the circadian system.
Genome-wide transcriptome proﬁling studies have provided
support for the view that a tight connection exists between
metabolism and the circadian system (reviewed in Dufﬁeld,
2003). According to these studies, about 15% of all genes
display daily oscillations in their expression; a large fraction of
these genes encode for important regulators of carbohydrate,
lipid, and cholesterol metabolism as well as for regulators of
detoxiﬁcation mechanisms. Among the regulatory genes identi-
ﬁed were transcription factors that serve as output regulators for
the circadian clock. In the liver, these include transcription
factors of the PAR bZip family such as DBP, TEF, and HLF
(Gachon et al., 2006) that bind to D-elements (Figure 2), the
PAR bZip-related repressor E4BP4 (Mitsui et al., 2001), the
Kru¨ppel-like factors KLF10 (Hirota et al., 2010a) and KLF15
(Jeyaraj et al., 2012), and nuclear receptors (Yang et al., 2006).
All of these transcription factors identiﬁed are known to regulate
genes involved in metabolism.
Systemic and Local Regulation of Metabolism
The timing of metabolism can be inﬂuenced by the circadian
system via systemic cues emanating from the SCN or through
local oscillators in peripheral tissues (Figure 1). Discrimination
between these two routes has been made possible by
comparing whole transcriptome analyses of mice with or without
functional liver clocks (Kornmann et al., 2007). Six out of seven
oscillating transcripts ceased to ﬂuctuate when local circadian
oscillators were arrested, indicating that they depend on local
oscillators in liver cells as opposed to systemic signals from
the SCN. These genes may be termed ‘‘locally clock-controlled
output genes’’ (Asher and Schibler, 2011). The remaining single
oscillating mRNA transcript continued to ﬂuctuate in a daily
manner with few changes in phase, amplitude, or magnitude.
These systemically driven liver clock genes most likely include
immediate early genes, which can convey rhythmic signals to
core clock genes in hepatocytes and are consequently involved
in the synchronization of liver clocks and genes directly involved
in rhythmic liver physiology and metabolic functions (centrally
clock controlled output genes, Asher and Schibler, 2011). Candi-
dates for the synchronization of the various body clocks in
mammals are heat-shock transcription factor 1 (HSF1) (Reinke
et al., 2008) and serum response factor 1 (SRF1).
The signaling pathways involved in the phase entrainment
of peripheral clocks are numerous and are just beginning to
be unraveled. To distinguish between SCN-dependent and
feeding-dependent regulators, the kinetics of feeding-induced
phase adaptation have been studied. Because the reversal of
feeding rhythms sends conﬂicting feeding messages and SCN
signals to peripheral organs, the effects of feeding rhythms on
phase adaptation in peripheral clocks have been studied either
in the absence of SCN-dependent glucocorticoid signaling or
of nutrient-dependent signaling. Ablation of glucocorticoid
receptor (GR) in the liver and inversion of feeding time have re-
vealed that GR and poly (ADP-ribose) polymerase 1 (PARP-1),
respectively, participate in the phase resetting of liver clocks.
While GR signaling is SCN dependent (Le Minh et al., 2001),
PARP1 is a feeding-dependent regulator (Asher et al., 2010).
Nutrient Sensors and Circadian Clock Components
To establish communication between circadian clocks and
metabolism, sensors affecting both systems exist as outlined
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below. These may include redox sensors, AMP/ATP ratio
sensors, glucose sensors, and fatty acid sensors (Figure 4).
Redox Sensors
The ﬁrst evidence for an involvement of redox state in circadian
clock regulation came from biochemical experiments that
revealed the sensitivity of CLOCK/BMAL1 and NPAS2/BMAL1
to the NAD(P)+/NAD(P)H ratio when binding to their cognate
E-box sequence (Rutter et al., 2001).Whereas the reduced forms
of NADH and NADPH stimulate binding, the oxidized forms
NAD+ and NADP+ strongly inhibit binding. Because NAMPT
(the enzyme driving the NAD+ salvage pathway) is transcription-
ally regulated by the circadian clock, NAD+ levels oscillate
daily in the cytosol and most likely in the nucleus as well
(Nakahata et al., 2009; Ramsey et al., 2009). Disruption of
NAD+ oscillation by mutations to NAD+ hydrolase CD38 alters
behavioral and metabolic circadian rhythms (Sahar et al.,
2011). Speciﬁcally, CD38-deﬁcient mice display shortened
circadian periodicity and alterations in plasma levels of amino
acids. These data illustrate the importance of oscillating NAD+
levels and highlight its importance in amino acid regulation.
Oscillating NAD+ levels also have indirect involvement in
the regulation of brain function because several amino acids,
such as tryptophan, tyrosine, glutamate, aspartate, glycine,
and GABA, are either precursors of neurotransmitters or
themselves neurotransmitters. Although NAD+ is modulated by
many additional processes (e.g., glycolysis, fatty acid synthesis),
its regulation via NAMPT reinforces coupling between the
circadian clock mechanism and NAD+-dependent metabolic
pathways.
In addition to the BMAL1/CLOCK and BMAL1/NPAS2 hetero-
dimers that can serve as sensors for the NAD(P)+/NAD(P)H ratio,
the NAD+-dependent enzymes SIRT1 and PARP-1 may also link
this metabolic ratio to the circadian clock. Levels of the enzyme
SIRT1, which deacetylates histones and several transcription
factors (Blander and Guarente, 2004), ﬂuctuate throughout the
day (Asher et al., 2008), and its activity may change as well
(Nakahata et al., 2008). This enzyme physically interacts with
BMAL1/CLOCK heterodimers, leading to a rhythmic deacetyla-
tion of BMAL1, histone H3 (Nakahata et al., 2008), and PER2
(Asher et al., 2008). As a result, the stability and/or activity of
these proteins may be affected and lead to changes in circadian
gene expression. Interestingly, SIRT1 also affects the activity of
other transcription factors such as PPARa (Purushotham et al.,
2009) and coactivator PGC-1a (Rodgers et al., 2005), high-
lighting another avenue for the modulation of circadian gene
expression and metabolism in the liver. Speciﬁcally, PGC-1a
appears to be tightly linked to the circadian clock mechanism
because it is expressed in a circadian fashion and serves as
a coactivator of ROR (Liu et al., 2007), an activator of several
clock components (see above and Figures 2 and 4). Further-
more, PGC-1a is a coactivator of FOXO1, which is part of
a fasting-inducible switch that modulates gluconeogenesis
(Liu et al., 2008). These relationships illustrate how circadian
mechanisms and energy homeostasis could be related. Another
Figure 4. Metabolic Regulators and
Circadian Clock Components
A schematic representation of the interactions
between metabolic input signals (yellow box) and
metabolic regulators (yellow, orange) with clock
(blue box) components of the positive limb (green)
and the negative limb (red) of the circadian clock
mechanism in the liver. Metabolic regulators
affected by input signals are represented in yellow.
Kru¨ppel-like factor 10 (KLF10), the PPARs and
REV-ERBs regulate Bmal1 expression by binding
to the corresponding recognition sequences in the
Bmal1 promoter. Levels of NAD+ inﬂuence SIRT1
activity, which deacetylates BMAL1, PER2, and
PGC-1a proteins. This leads to PGC-1a-mediated
coactivation of Bmal1 expression together with
ROR. Deacetylated PER2 is marked by b-TRCP
(F-Box protein of ubiquitin ligase complexes)
for degradation. Deacetylated BMAL1 (which can
be acetylated by CLOCK) leads to reduced binding
potential to E-boxes. The ratio of NAD+/NADH
modulates this binding. Oscillating PARP1 activity
regulated by an unknown factor modulates
CLOCK via ribosylation (orange tail). Liver kinase
B (LKB) phosphorylates AMPK when the AMP/
ATP ratio increases. Then, AMPK phosphorylates
CRY1, thereby targeting it for degradation by
FBXL3 (an F-box protein of ubiquitin ligase com-
plexes). Interactions involving metabolic regula-
tors are represented by yellow arrows. Metabolic
output is indicated by the PER2/PPAR and
CRY/glucocorticoid receptor (GR) complexes
(Purple arrows). Ac = acetyl group and p = phos-
phate group (modiﬁed from Asher and Schibler,
2011).
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potential NAD+ sensor is PARP-1 (Asher et al., 2010), a feeding-
dependent factor implicated in the phase entrainment of periph-
eral oscillators. Illustrating a possible way to orchestrate
feeding-induced phase changes and glucose homeostasis,
PARP1 acts by binding to FOXO1 and attenuating the transacti-
vation potential of the latter (Sakamaki et al., 2009).
Nuclear Receptors as Sterol, Fatty Acid, and
Glucocorticoid Sensors
Several organic molecules serve as ligands for nuclear recep-
tors, which regulate speciﬁc genes in response to ligand binding.
Therefore, these receptors control the development, homeo-
stasis, and metabolism of an organism. Of the 49 nuclear recep-
tors, 20 have been reported to display a circadian pattern of
mRNA expression in the liver, 19 in white adipose tissue, 18 in
brown adipose tissue, and seven in muscle (Yang et al., 2006).
The receptors that display these circadian patterns include
various isoforms of PPAR, REV-ERB, ROR, and TR. Some of
these receptors, such as the REV-ERBs and the RORs, are
directly involved in the modulation of the core clock circuitry
(Figure 2) and may interact with clock components including
PER2 (Schmutz et al., 2010) and CRY (Lamia et al., 2011). Other
nuclear receptors, including LXR and FXR, can either stimulate
or repress genes that produce molecular ligands; one example
is the regulation of Cyp7a1. This gene encodes for the rate-
limiting enzyme that converts cholesterol to bile acids (Peet
et al., 1998), possibly affecting the intracellular levels of sterol
compounds that suppress the transactivational activities of the
core clock factors RORa and RORg in the liver.
Fatty acids and their intermediates are natural ligands for
PPARs. PPARs regulate adipocytes and insulin sensitivity
(PPARg), modulate the fatty acid oxidation system in mitochon-
dria (PPARa), and regulate cell proliferation, differentiation,
and migration in wound healing and inﬂammatory processes
(PPARd). The isoforms PPARa and PPARg have been shown
to interact (directly or indirectly) with PER2 (Grimaldi et al.,
2010; Schmutz et al., 2010), leading to a time-of-day-dependent
modulation of lipid metabolism (Figure 4) (Grimaldi et al., 2010).
In addition, PER3 appears to form a complex with PPARg,
leading to reduced transactivation potential of this nuclear
receptor. Accordingly, an increase in adipose tissue and a
decrease in muscle tissue were observed in Per3-deﬁcient
mice (Costa et al., 2011). Interestingly, PER2 appears to regulate
gamma interferon production in natural killer cells (Liu et al.,
2006), pointing to a potential modulatory function of PER2 for
PPARd.
Regulation of glucose homeostasis involves glucocorticoids
and its receptor. A recent study reported that the clock compo-
nents of the cryptochrome (Cry) family interact with GR and
modulate glucose homeostasis (Figure 4) (Lamia et al., 2011).
This interaction reduces GR activation potential for the
expression of the phosphoenolpyruvate caboxykinase 1 gene
(Pck1)—a gene that encodes the rate-limiting enzyme in gluco-
neogenesis (PEPCK). Accordingly, Cry-deﬁcient cells increased
Pck1 expression in response to dexamethason (a synthetic
glucocorticoid). In contrast the NF-kB signaling pathway,
through which glucocorticoids modulate inﬂammation, was not
affected. This indicates a separation of CRY function in the glu-
coneogenic and inﬂammatory pathways of glucocorticoid action
(Lamia et al., 2011). Therefore, modulation of CRY levels may be
a potential therapeutic strategy to reduce the side-effects of
glucocorticoids on metabolism (i.e., hyperglycemia and dia-
betes) during anti-inﬂammatory treatment.
Glucose and AMP/ATP Sensors
Application of high glucose concentrations to ﬁbroblast cell
cultures leads to acute transcriptional repression of the Per1,
Per2, and Bmal1 genes, thereby synchronizing ﬁbroblast clocks
(Hirota et al., 2002). This is reminiscent of glucocorticoid or
glucocorticoid analog synchronization of cell cultures (Balsalo-
bre et al., 2000), with the difference being that they induce
Per1 and Per2 gene expression that leads to a repression of their
own transcription and subsequent synchronization of all cells
within hours. Glucose appears to upregulate TIEG1 (KLF10),
a negatively acting zinc-ﬁnger transcription factor (Hirota et al.,
2002). It binds to two GC-rich elements in the Bmal1 promoter
and thereby represses Bmal1 transcription. In vitro experiments
have shown that siRNA-mediated knockdown of TIEG1/KLF10
causes period shortening of cellular bioluminescence rhythms
driven by Bmal1-luciferase and Per2-luciferase reporters (Hirota
et al., 2010a). Interestingly, Tieg1/Klf10 is regulated by BMAL1/
CLOCK and thus appears to be part of a feedback loop involving
the circadian clock and glucose levels (Guillaumond et al., 2010)
(Figure 4). Accordingly, glucose absorbed with food or gener-
ated by gluconeogenesis will stimulate Tieg1/Klf10 expression
and reduce the expression of Bmal1 and genes encoding for
enzymes involved in gluconeogenesis. In line with this notion is
the observation that Klf10 knockout mice display postprandial
and fasting hyperglycemia, although curiously, this has only
been observed in male mice. However, KLF10 is implicated in
circadian lipid and cholesterol homeostasis in females (Guillau-
mond et al., 2010). Collectively, it appears that TIEG1/KLF10 is
a transcriptional regulator that links the circadian clock to energy
metabolism in the liver.
One measure of metabolic state is the ratio between AMP and
ATP. Once the ratio increases (high AMP levels), cells reduce the
activity of ATP-consuming pathways and increase the activity
of ATP-generating pathways. A major sensor for the AMP/ATP
ratio is adenosine monophosphate-dependent protein kinase
(AMPK), which becomes activated when AMP binds to its
g-subunit. This binding elicits a structural change in the AMPK
catalytic a-subunit, making it a substrate for liver kinase B1
(LKB1). LKB1 then phosphorylates a threonine in the a-subunit
of AMPK, leading to activation of AMPK (Carling et al., 2011).
It appears that AMPK impacts circadian clock mechanisms in
various ways. It can directly phosphorylate CRY1, leading to
destabilization and degradation of this core clock protein (Lamia
et al., 2009) and consequently affecting the negative limb of the
circadian clock mechanism (Figure 4). The activity of AMPK
kinase also appears to modulate PER2 protein stability via an
indirect mechanism involving casein kinase 1ε (CK1ε). AMPK
phosphorylates S389 of CK1ε, enhancing CK1ε-mediated phos-
phorylation of PER2, which in turn leads to accelerated degrada-
tion of PER2. Accordingly, a lack of the catalytic subunit a-2 of
AMPK would lead to an accumulation of PER2, which has been
observed in Ampka2 knockout mice (Um et al., 2007). Taken
together, it appears that AMPK is another potential regulator of
the coupling between metabolism and the circadian clock.
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The interplay between the clock and metabolism is not only
apparent at the cellular level, but also at the systemic level.
This is discussed in the next sections.
Integration of Light, Food, and Reward Signals
in the Midbrain for Dynamic Entrainment
of the Circadian System
Light Signals
Areas in the brain responsible for metabolic integration (the
PVN, sPVZ, DMH, and ARC) and reward integration (HB) receive
direct light signals from ipRGCs (Figure 5, black arrows), as
revealed by retrograde labeling (Qu et al., 1996) and transgenic
ganglion cell tracing (Hattar et al., 2006). Light information
also reaches these areas indirectly via the SCN and the
pineal gland (Pin) (Figure 5, red arrows) (Morin, 2007). These
ﬁndings illustrate that environmental light information can reach
areas deep in the brain and potentially affect regulation of
metabolism and reward integration simultaneously. To some
degree, feeding and reward may be coupled by the light/dark
cycle, and 24 hr oscillations may be maintained in these brain
areas to ensure proper coordination of physiology in the
organism (see below).
SCN
sPVZ
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DMH
VTA
NAc
VLPO
HB
Reward integration
LH
Metabolic integration
Light/Dark Food
ARC
NPY/AgRP POMC/CART
Timing
Internal circuit
External input
Pin
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Motor 
coordination
and activity
SN
Brain
stem
Ghrelin     Leptin
Photons
orexin
Figure 5. Major Neural Pathways
Integrating Light and Feeding Signals
Light signals are directly transmitted to three
entities in the brain (black arrows): (1) Structures
important for timing (red), such as the SCN and
Pin; (2) structures important for metabolic inte-
gration (yellow), such as the sPVZ; and (3) struc-
tures important for reward integration (blue), such
as the HB. Light information is indirectly trans-
mitted from the SCN and Pin (red arrows). The
SCN projects to areas important for metabolic
integration including the PVN, sPVZ, DMH, and
ARC. The Pin transmits light information to the HB.
Feeding signals (leptin and ghrelin) primarily affect
two entities in the brain (green arrows): (1) the ARC,
which is important for the metabolic integration of
feeding signals (yellow), and (2) the VTA, which is
important for the integration of reward (blue). The
structures important for metabolic integration
(yellow) and reward integration (blue) exchange
information with each other (yellow and blue
arrows) and can affect the SCN and Pin timing
centers (red). Light and feeding signals combine
and contribute to motor coordination and activity
(purple).
ARC, arcuate nucleus; DMH, dorsomedial hypo-
thalamus; HB, habenula; ipRGC, intrinsically
photosensitive retinal ganglion cell; LH, lateral
hypothalamus; NAc, nucleus accumbens; Pin,
pineal gland; PVN, paraventricular nucleus; SCN,
suprachiasmatic nuclei; SN, substantia nigra;
sPVZ, subparaventricular zone; VLPO, ventrolat-
eral preoptic nucleus; VTA, ventral tegmental area.
Light information also indirectly rea-
ches peripheral organs including the
adrenal glands, the liver, and the
pancreas. The SCN distribute a rhythmic
signal to all tissues of the body via
hormones and the autonomous nervous
system (Buijs et al., 1998). The SCN’s
control of glucocorticoid secretion is thought to be an important
example of SCN inﬂuence on peripheral clocks. Light can indi-
rectly activate the adrenal gland via the SCN to affect gene
expression and glucocorticoid release (Ishida et al., 2005).
Thus, the adrenal circadian clock is entrained by light and the
adrenal clock gates glucocorticoid production in response to
adrenocorticotropic hormone (ACTH) (Oster et al., 2006).
Furthermore, nocturnal light affects clock gene expression in
the liver via the SCN and the autonomic nervous system (Cailotto
et al., 2009). Light also directly affects the pineal gland, in which
melatonin synthesis takes place. Light that is applied during
the dark phase results in a suppression of melatonin secretion.
Interestingly, melatonin receptors are present in the pancreas,
and the rhythms of insulin secretion by b-cells can be phase-
shifted by the introduction of melatonin (Mulder et al., 2009).
This implies that light inﬂuences pancreatic insulin secretion
via the suppression of nocturnal melatonin. This suggests an
indirect inﬂuence of light on the mechanisms of glucose homeo-
stasis, supporting the ﬁnding that melatonin signaling affects
insulin secretion (Mu¨hlbauer et al., 2009). The importance of light
input for regulating physiological mechanisms that impact
human well-being is underscored by the fact that light therapy
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can be very effective for the treatment of certain mood and
eating disorders, such as seasonal affective disorder (Prasko,
2008) and night eating disorder (Goel et al., 2009).
Feeding Signals
A second external input to the metabolic and reward systems of
the brain are feeding signals. These signals affect the homeo-
static control of feeding as it relates to the regulation of energy
balance (Figure 5, metabolic integration), and they also regulate
hedonic aspects of feeding (Figure 5, reward integration)
(reviewed in Lutter and Nestler, 2009).
Circulating hormones, such as ghrelin and leptin, relay infor-
mation about peripheral energy levels to the brain and control
feeding homeostasis (Figures 1A and 5). Ghrelin is secreted in
anticipation of a regularly scheduled mealtime by the oxyntic
gland cells in the stomach, which leads to activation of ghrelin
receptors expressed primarily on NPY/AgRP (Agouti-related-
peptide) neurons within the arcuate nucleus (Figure 5, ARC).
This process promotes feeding behavior (reviewed in Zigman
and Elmquist, 2003) and an increase in locomotor activity that
is termed ‘‘food anticipatory activity’’ (FAA). Because ghrelin
administration affects clock phase in the SCN in vitro and
advances wheel-running behavior following food deprivation, it
appears that ghrelin not only affects the metabolic integration
centers of the brain but also the circadian system (Yannielli
et al., 2007) that regulates FAA activity. Oxyntic cells coexpress
ghrelin and the circadian clock proteins PER1 and PER2 in
a circadian fashion, and Per1/2 double mutant animals lack
ghrelin expression (LeSauter et al., 2009). This implies an
involvement of the molecular clock mechanism in circadian
regulation of ghrelin production and/or release. Because mice
lacking ghrelin receptors display reduced FAA, and mice mutant
in the Per2 gene show no FAA (Feillet et al., 2006), it is conceiv-
able that there is a food-entrainable oscillator (FEO) in ghrelin-
secreting stomach cells. This stomach FEO could partially affect
clocks in the ARC of the brain. Additional FEOs in other tissues
can be envisioned, such as in the liver and the brain, and these
could potentially act via leptin or other feeding-related hormones
including NPY and PYY (peptide YY).
Leptin synthesized and secreted by white adipose tissue
suppresses food intake and stimulates metabolic processes
that dissipate excess energy storage (reviewed in Zigman and
Elmquist, 2003). Circadian oscillations in leptin have been
observed in the plasma of rats (Sukumaran et al., 2010) and
may activate leptin receptors in a time-dependent fashion.
Leptin receptors are expressed in the ARC (Figure 5) in neurons
that also express pro-opiomelanocortin (POMC) and cocaine-
amphetamine-regulated transcript (CART), as well as in NPY-
and AgRP-expressing neurons. Activation of leptin receptors in
POMC/CART neurons stimulates the activity of these neurons
and suppresses feeding while increasing metabolic rate. In
contrast, activation of leptin receptors in NPY/AgRP neurons
inhibits the activity of the proappetite NPY/AgRP neurons (Saper
et al., 2002), reinforcing the suppression of food intake and
opposing the effects of ghrelin (see above). Interestingly, leptin
stimulates the transcription factor STAT3, which in conjunction
with the transcription factor Nhlh2 regulates transcription of
prohormone-converting enzymes 1 (PC1) and 2 (PC2) (Fox and
Good, 2008). These enzymes are involved in the conversion of
POMC to various hormones, such as ACTH, and various types
of melanocyte-stimulating hormones (MSH) (reviewed in
Mountjoy, 2010). Central administration of a-MSH reduces
appetite and increases energy expenditure (Cone, 2006) via its
actions on melanocortin receptors (Mc3r and Mc4r) (Cone,
2006). Lack of Mc3r in mice leads to reduced FAA under
restricted feeding conditions, and the expression of the clock
genes Npas2 and Per2 in the cortex is also reduced (Sutton
et al., 2008). These observations are consistent with the reported
reduction or absence of FAA in mutant mice that lack clock
components Npas2 or Per2, respectively (Dudley et al., 2003;
Feillet et al., 2006). Collectively, it appears that circadian leptin
in the serum binds to its receptors in a time-dependent fashion,
thereby activating neurons in the ARC andmodulating transcrip-
tion of target genes in a 24 hr cycle. However, the details of
how this is achieved are still a matter of investigation.
Reward Signals
There is surmounting evidence to support the theory that the
consumption of both food and drugs of abuse converge on
a shared pathway within the limbic system that mediates
motivated behaviors (reviewed in Simerly, 2006). Much of the
research has focused on the mesolimbic dopamine pathway
because common drugs of abuse increase dopamine signaling
from nerves that originate in the ventral tegmental area (VTA)
and project to the nucleus accumbens (NAc), which is part of
the striatum (Figure 5) (Nestler and Carlezon, 2006). An increase
in dopaminergic transmission is thought to occur either by direct
action of drugs on dopaminergic neurons (cocaine, nicotine)
or indirectly by inhibition of GABAergic interneurons in the
VTA (alcohol, opiates). In addition, the peptide neurotransmitter
orexin, which is expressed in a subset of neurons in the lateral
hypothalamus (LH) that have projections to the VTA, is also impli-
cated in mediating drug-induced activation of dopaminergic
neurons in the VTA (Borgland et al., 2006). Interestingly, the acti-
vation of orexin neurons appears to be under circadian control
(Marston et al., 2008), linking arousal and drug-induced behavior
by the circadian clock mechanism.
Natural rewards such as food induce similar responses in the
mesolimbic dopamine pathway (Kelley and Berridge, 2002).
Presentation of palatable food induces the release of dopamine
into the NAc, which in turn promotes the animal’s behavioral
attempts to obtain food rewards via increased arousal and
psychomotor activation. It appears that taste receptors are not
required for this process to occur (de Araujo et al., 2008), but
orexin neurons in the LH may be activated during feeding, which
consequently causes the release of orexin directly onto VTA
dopamine neurons (Figure 5) (Zheng et al., 2007). In transgenic
orexin neuron-ablated mice, FAA was reduced in conjunction
with attenuated expression of clock genes (Npas2, Bmal1,
Per1) in the forebrain (Akiyama et al., 2004). This ﬁnding indicates
a relationship between orexin and the circadian clock. Further-
more, daily ﬂuctuations of orexin in the cerebrospinal ﬂuid are
maintained in rats housed under constant dark conditions. More-
over, lesions of the SCN in rats ablated circadian rhythms of
orexin-A (Zhang et al., 2004). These ﬁndings indicate that orexin
levels are regulated by the circadian clock. However, whether
orexin expression is regulated by circadian components or is
under indirect control of the circadian clock is not known.

ht
tp
://
do
c.
re
ro
.c
h
Leptin and ghrelin also exert effects on themotivation to obtain
food through their regulation of mesolimbic dopamine signaling
in the VTA (Figure 5). Dopamine neuron ﬁring in the VTA is
inhibited by leptin receptor activation (Fulton et al., 2006)
whereas blocking leptin signals in the VTA increases locomotor
activity and food intake (Hommel et al., 2006). These data are
consistent with the ﬁnding that basal secretion and feeding-stim-
ulated release of dopamine can be decreased by leptin in the
NAc of rats (Kru¨gel et al., 2003). Imaging studies in human
subjects conﬁrm the involvement of the mesolimbic dopamine
(DA) system in leptin’s actions (Farooqi et al., 2007). A recent
study indicates that leptin receptor-expressing neurons in the
lateral hypothalamus (LH) that coexpress neurotensin mediate
the physiological actions of leptin. These specialized neurons
innervate local orexin neurons and the VTA neurons in the
mesolimbic DA system (Leinninger et al., 2011). Removing the
leptin receptor from these LH neurons causes mice to have
orexin neurons that are unresponsive to fasting and diminished
amphetamine responses in the mesolimbic DA system, resulting
in reduced locomotor activity in these animals (Leinninger
et al., 2011). These observations indicate that leptin may impact
orexin neurons and the mesolimbic DA system to control energy
balance. In contrast to leptin, ghrelin administration in rodents
stimulates the release of dopamine into the NAc via activation
of its receptors in the VTA (Jerlhag et al., 2007), mimicking the
process that is observed in humans (Malik et al., 2008).
Components of the circadian clock modulate dopamine levels
in the NAc of mice via direct regulation of monoamine oxidase A,
a key enzyme in dopamine degradation. This ﬁnding implies that
the circadian clock is involved in the regulation of the reward
system (Hampp et al., 2008). As a consequence, the efﬁciency
of dopaminergic signaling in the mesolimbic dopaminergic
system is modulated by dopamine degradation caused by the
circadian clock. Accordingly, the amount of dopamine, which
is released from the VTA, in the NAc in response to leptin- or
ghrelin- induced signaling is modulated in a time-dependent
fashion. In this manner, a systemic integration of time and food
signals is achieved, balancing energy homeostasis. This concept
is also illustrated by the ﬁnding that the regulation of dopami-
nergic transmission and reward is altered in mice mutant for
the gene Clock and associated with increased expression and
phosphorylation of tyrosine hydroxylase (TH) (McClung et al.,
2005), the rate-limiting enzyme for dopamine synthesis. Addi-
tionally, these mutants show elevated leptin levels (Turek et al.,
2005), which may be responsible for the elevated TH activity,
because leptin increases the synthesis and activity of TH (Fulton
et al., 2006). As a consequence, these animals probably have
elevated dopamine levels contributing to themania-like behavior
(Roybal et al., 2007) and the increased ﬁring rate of VTA dopami-
nergic neurons observed in these animals (Mukherjee et al.,
2010).
Desynchrony of the Circadian System: Implications
for Human Diseases
The circadian system is strongly entwined with metabolism (see
above, Dallmann et al., 2012), organizing it in a temporal fashion
that optimizes the organism’s performance over the day’s 24 hr.
Concurrently, this organization ensures tissue homeostasis by
keeping various physiological processes in balance. Perturba-
tions of the circadian system caused by rotating shift work,
frequent transmeridian ﬂights and stress lead to de-synchroniza-
tion of the various body clocks. This is likely to be a confounding
factor that favors the development of diseases such as meta-
bolic syndrome (obesity, diabetes, cardiovascular problems)
and neurological disorders. In these disorders, energy uptake
and expenditure, and neuronal activation and inhibition become
imbalanced.
Studies in humans suggest that disruption of daily metabolic
rhythms is an exacerbating factor in the metabolic syndrome
(Gallou-Kabani et al., 2007). Shift-work and sleep deprivation
are known to dampen rhythms in growth hormone and mela-
tonin, reduce insulin sensitivity, and elevate circulating cortisol
levels (Spiegel et al., 2009). These changes favor weight gain,
obesity, and development of metabolic syndrome. Recently,
forced circadian desynchronization (a simulation of shift work)
in humans was shown to impact on neuroendocrine control of
glucose metabolism and energetics (Scheer et al., 2009). Partic-
ipants subjected to the shift-work protocol showed increased
blood pressure, inverted cortisol rhythms accompanied by
hypoleptinemia and insulin resistance (Scheer et al., 2009). Inter-
estingly, patients with diabetes display dampened rhythms of
glucose tolerance and insulin secretion (Boden et al., 1999), indi-
cating that the relationship between circadian disruption and
metabolic pathologies is bidirectional (Figure 1B, pink arrows).
This suggests that circadian disruption may lead to a vicious
cycle contributing to the augmentation and progression of
metabolic syndrome. The importance of a functional circadian
system for metabolic homeostasis is evident from studies in
mice with disrupted clock function (see above). For example,
Clockmutant mice exhibit a reduced metabolic rate and obesity
(Turek et al., 2005) and further show impaired glucose tolerance,
reduced insulin secretion, and defects in size and proliferation
of pancreatic islets (Marcheva et al., 2010).
Metabolic disorders, eating disorders and obesity are often
associated with mood disorders in humans (McIntyre, 2009).
This association is paralleled in a mouse model in which the
Clock gene has been mutated. These animals display metabolic
problems and obesity (Turek et al., 2005) and a behavior reminis-
cent of mania in bipolar disorder patients (Roybal et al., 2007)
(see above). As with metabolic syndrome, chronic shift-work
may favor the development of mood disorders (Scott, 2000),
probably due to a misalignment of rhythms in body temperature,
melatonin, and sleep (Hasler et al., 2010). Conversely, individuals
that suffer from mood disorders beneﬁt from strict daily routines
including strictly followed bed- andmealtime (Frank et al., 2000).
These routines probably help to entrain and synchronize the
plethora of clocks in the body to maintain the integrity of the
circadian system and physiology (Hlastala and Frank, 2006).
One of the mood disorders related to misalignment between
environmental external and body internal rhythms is seasonal
affective disorder (SAD). It is characterized by depressive symp-
toms that occur during the winter (Magnusson and Boivin, 2003).
Because light therapy is an efﬁcient method for the treatment
of SAD (Terman and Terman, 2005) it is hypothesized that
light, which suppresses melatonin secretion by the pineal gland
(Figure 1A), may entrain the circadian system via this humoral
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pathway and by resetting clock phase in the SCN (see above)
and may synchronize humoral and neuronal signaling in the
brain. However, the mechanism of how light mediates the
beneﬁcial effects for the treatment of mood disorders is not
completely understood.
A dysfunctional circadian system can affect mood-related
behaviors as evidenced by genetic alterations in clock genes
of mice. Amutation in theClock gene is accompanied by a spec-
trum of behavioral abnormalities including mania and hyperac-
tivity (Roybal et al., 2007). Additionally, these animals as well
as animals mutant in the Per genes display altered sensitization
to, and preference for, drugs of abuse such as cocaine (Abarca
et al., 2002; McClung et al., 2005) and alcohol (Dong et al., 2011;
Spanagel et al., 2005). Clock genemutations appear to affect the
dopaminergic system (see above, Hampp et al., 2008; Roybal
et al., 2007), but also other neurochemical systems appear to
be affected. Expression of the glutamate transporter Eaat1 is
reduced in Per2 mutant mice, leading to decreased uptake of
glutamate by astrocytes and increased extracellular glutamate
levels. Moreover, the increased alcohol consumption observed
in these animals was reversed by acamprosate (Spanagel
et al., 2005) a pharmacological agent believed to reduce abnor-
mally high glutamatergic activity.
The interactions between circadian clocks and neurochemical
mechanisms in the brain appear to be complex andmay illustrate
the pleiotropy of clock genes. This pleiotropy may be key to
temporally coordinate and couple mechanistically unrelated
physiological pathways such as weight and mood regulation,
which once uncoupled may favor development of obesity and
depression.
Perspectives
Because the circadian system appears to be involved in
a number of diseases including obesity and depression, it may
be an entry point for the development of treatments for these
diseases. As highlighted in this review, light and food can signif-
icantly impact the circadian system; this implies that lifestyle
affects human health via the circadian system with nutrition,
movement and light exposure as the key elements involved.
Nuclear receptors, kinases, and molecules such as melatonin
are a part of the circadian system. It is thus plausible that phar-
macological agents acting on these components or mimicking
their actions may serve as a conduit to ameliorate health prob-
lems associated with the circadian clock.
One modulator of kinase activity is lithium, which inhibits
GSK3b activity. This kinase regulates clock components such
as REV-ERBa (Yin et al., 2006) and PER2 (Iitaka et al., 2005),
lengthens the circadian period (Li et al., 2012), and thus may
relay the beneﬁcial effects of lithium in the treatment of depres-
sive disorders (Johnsson et al., 1983). However, its precise
mechanism of action is not understood. Another potential phar-
macological target to alter the circadian clock is casein kinase 1d
(CK1d). Application of a CK1d inhibitor (PF-670462) to wild-type
mice lengthened circadian period accompanied by nuclear
retention of the clock protein PER2. This treatment lengthened
the period in a phase speciﬁc manner, selectively extending
the duration of PER2-mediated transcriptional feedback (Meng
et al., 2010). This suggests that CK1d inhibitionmight be effective
in increasing the synchronization of disrupted circadian oscilla-
tors offering an avenue for therapeutic treatment of diseases
caused by disrupted or desynchronized circadian rhythms.
Recently, longdaysin, a molecule that targets three kinases,
CK1a, CK1d, and ERK2, was discovered during a large-scale
chemical screen. Longdaysin inhibition of CK1a reduced
PER1 phosphorylation and degradation. As a consequence,
the clock periods in human cells and in zebraﬁsh embryos
became longer, pointing to a therapeutic potential of longdaysin
in manipulating and synchronizing circadian clocks (Hirota et al.,
2010b).
Another approach to modulate clock activity is through
delivery of substances thatmodulate the action of nuclear recep-
tors. For example GSK4112 (SR6452) competes with heme for
the binding to proteins of the REV-ERB family tomodulate adipo-
genesis in mice (Kumar et al., 2010) and SR9011 as well as
SR9009 regulate circadian behavior and metabolism (Solt
et al., 2012). Synthetic molecules binding to proteins of the
ROR family have been identiﬁed as well (Kumar et al., 2011;
Wang et al., 2010); however, their action on the circadian clock
and on diseases related to metabolism or mood disorders has
not been established and is currently under investigation.
The circadian system is undoubtedly involved in a spectrum of
disorders including metabolic and mood disorders. Circadian
dysfunction can be either a contributing factor or a consequence
of disease. Therefore, targeting the circadian clock for strength-
ening homeostatic mechanisms may be a promising therapeutic
aim. This may be achieved either by pharmacological agents or
by strengthening the clock via natural input such as light and
feeding. Circadian pharmacology has just witnessed its dawn
and holds a strong future given the promise of newly discovered
agents and their effective modes of action.
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